Beyond the Sequence: Advancing siRNA Leads for CNS Delivery
- Aerska is developing siRNAs for CNS indications
- Aerska’s lead program is APP Program for the treatment of Alzheimer’s Disease
- Aerska will be presenting their approach in siRNA lead development to identify a potent sequence and the delivery strategy to reach CNS